Xiaflex: Phase II started

BioSpecifics Technologies started a double-blind, U.S. Phase II trial of Xiaflex in 20 adult patients with >=2 benign lipomas of similar size. Patients will have 1 lipoma treated with Xiaflex, while the other will receive placebo.

Auxilium has exclusive, worldwide rights from BioSpecifics to

Read the full 443 word article

User Sign In